Kadam Sachin S, Tripathi Pradeep, Jagtap Rohan, Kapoor Rajat, Kadam Tejaswini, Bhandarkar Prashant, Shimpi Sakshi
Department of Surgical Oncology, Vedant Cancer and Multispeciality Hospital, Thane, Maharashtra India.
Department of General, Laparoscopic & Bariatric Surgery, Vedant Cancer and Multispeciality Hospital, Thane, Maharashtra India.
Indian J Surg Oncol. 2022 Jun;13(2):322-328. doi: 10.1007/s13193-021-01457-8. Epub 2021 Oct 4.
Breast cancer is the most common cancer in women in urban India and surgery has one of the definitive roles in treating this cancer. Over the decades, multiple studies have been published and they have shown that BCS followed by radiotherapy has equivalent disease-free survival (DFS) and overall survival (OS) as compared with MRM. The surgeon has the main role in explaining the treatment options to the patient. It is a prospective study conducted at Vedant Cancer and Multispeciality Hospital in a metropolitan city, Thane, India. Patients with stage I or II breast cancer with tumor size less than 5 cm were included in the study. Patients with locally advanced and metastatic breast cancer were excluded from the study. The study population was early breast cancer patients registered and waiting for surgery ( = 86) at Vedant Cancer and Multispeciality Hospital from November 2019 to end of April 2020. The total number of females enrolled in the study were 86 and out of this, 79.1% ( = 68) females opted for MRM and 20.9% ( = 18) females opted for BCS in which 8 patients had changed their decision after re-counseling in the ward from MRM to BCS. The most common reasons selected by patients to undergo MRM were fear of cancer recurrence (30.2%, = 26), avoidance of side effects of radiation therapy (25.5%, = 22) and fear of radiation therapy (23.2%, = 20). Surgeon had decided the surgical option in 79.1% ( = 68) cases. The study shows that the treating surgeon and patient's husband are the principal persons who decide the surgical option and active participation of women during counseling is an important factor.
The online version contains supplementary material available at 10.1007/s13193-021-01457-8.
乳腺癌是印度城市女性中最常见的癌症,手术在治疗这种癌症中起着决定性作用之一。几十年来,已经发表了多项研究,这些研究表明,保乳手术(BCS)联合放疗与乳房根治术(MRM)相比,具有相同的无病生存率(DFS)和总生存率(OS)。外科医生在向患者解释治疗方案方面起着主要作用。这是一项在印度孟买塔纳市的韦丹特癌症及多专科医院进行的前瞻性研究。研究纳入了肿瘤大小小于5厘米的I期或II期乳腺癌患者。局部晚期和转移性乳腺癌患者被排除在研究之外。研究人群为2019年11月至2020年4月底在韦丹特癌症及多专科医院登记并等待手术的早期乳腺癌患者(n = 86)。参与研究的女性总数为86名,其中79.1%(n = 68)的女性选择了乳房根治术,20.9%(n = 18)的女性选择了保乳手术,其中8名患者在病房重新咨询后从乳房根治术改为保乳手术。患者选择乳房根治术的最常见原因是害怕癌症复发(30.2%,n = 26)、避免放疗副作用(25.5%,n = 22)和害怕放疗(23.2%,n = 20)。79.1%(n = 68)的病例由外科医生决定手术方案。研究表明,主刀医生和患者的丈夫是决定手术方案的主要人员,女性在咨询过程中的积极参与是一个重要因素。
在线版本包含可在10.1007/s13193-021-01457-8获取的补充材料。